We further identified increased expression of T cell exhaustion markers LAG3 and PTPN6, as well as interferon-related genes and elevated APOBEC3A activity in this recurrence, suggesting a combination of immune-regulated and tumor cell-intrinsic APOBEC3A-mediated resistance to CPI in the progressing lesion. This evidence concerns the gene LAG3 and neoplasm.